Sunday, May 29, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Study identifies a novel class of angiotensin receptor blockers that interfere with SARS-CoV-2 spike – ACE2 interaction

by Medical Finance
in Coronavirus
Study: Discovery of a new generation of angiotensin receptor blocking drugs: receptor mechanisms and in silico binding to enzymes relevant to covid-19. Image Credit: Kateryna Kon/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

Scientists have discovered a new generation of angiotensin receptor blockers that may be used to treat coronavirus disease 2019 (COVID-19).

The in-silico docking and molecular dynamics studies have shown that these drugs are capable of preventing the interaction between human angiotensin-converting enzyme 2 (ACE2) and the spike receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-C0V-2).

Study: Discovery of a new generation of angiotensin receptor blocking drugs: receptor mechanisms and in silico binding to enzymes relevant to covid-19. Image Credit: Kateryna Kon/Shutterstock
Study: Discovery of a new generation of angiotensin receptor blocking drugs: receptor mechanisms and in silico binding to enzymes relevant to covid-19. Image Credit: Kateryna Kon/Shutterstock

The study has recently been published in the Computational and Structural Biotechnology Journal.

Background

According to the available literature, there is an association between the pathogenesis of cardiovascular disease and COVID-19. In severe COVID-19 patients with pneumonia, the development of hyperinflammation or “cytokine storm” is related to the overexpression of angiotensin II in the renin-angiotensin system. In this context, studies have shown that hypertensive COVID-19 patients who take angiotensin receptor blockers have lower morbidity and mortality than those without medication.

The cleavage of SARS-CoV-2 spike protein by furin and 3CLpro is required to initiate viral entry into host cells. The entire process is operated through the charge relay system. Tyrosinate in angiotensin II, serinate in furin, and cysteinate in 3CLpro are anions created through the charge relay systems. The activities of these residues are triggered through their nucleophile anions. The charge relay systems mediating the activity of furin and 3CLpro are similar to those that mediate the activity of angiotensin II.

In the current study, the scientists have identified a new generation of sartan-like angiotensin II receptor blockers that are known to inhibit the receptors more strongly than currently available sartans. Sartans are a group of type 1 angiotensin receptor antagonists that modulate the function of the renin-angiotensin system and are used to treat high blood pressure.

The new generation of angiotensin receptor blockers discovered in the study have been referred to as bisartans. These bisartans are novel bis-alkylated imidazole sartan derivatives bearing dual symmetric anionic biphenyl tetrazole moieties.    

Important observations  

The bisartans discovered in the study were categorized into two sub-types. In bisartans A and B, the aliphatic butyl group is attached at position 4 of the imidazole ring. In bisartans C and D, the butyl group is attached at position 2 of the imidazole ring. 

In-silico docking experiments were conducted to determine whether these bisartans are able to interact with the components involved in the SARS-CoV-2 entry process, including ACE2, spike RBD, furin, and 3CLpro.

The findings revealed that the bisartans bind to the arginine residues present in the viral spike furin cleavage site. Specifically, bisartan A showed more robust binding to the mutated furin cleavage site of the SARS-CoV-2 delta variant than that to the wildtype cleavage site.

Further molecular docking experiments revealed that two negatively-charged tetrazoles of bisartan A bind to positively-charged arginine and histidine residues in the spike furin cleavage site. In addition, bisartans showed stable binding to the Zn2+ domain of the ACE2 catalytic site.

The number of arginine and histidine residues involved in the formation of bisartans-spike RBD-ACE2 complex was higher than that involved in the sartans-spike RBD-ACE2 complex. These observations indicate that bisartans have higher binding affinities for the ACE2-spike complex than currently available sartans.

Overall, these findings indicate that bisartans are capable of inhibiting the function of furin, and thus, can block the process of viral entry into host cells. Further experiments revealed that bisartans inhibit the interaction between viral spike and ACE2 without altering the physiological activity of ACE2 in reducing the angiotensin II level.   

Despite having the ability to interfere with spike-ACE2 interaction as well as 3-CL protease, bisartans failed to inhibit SARS-CoV-2 infection in COVID-19 bioassays. This could be because of their poor cell membrane permeability. The presence of an equal number of positively- and negatively charged functional groups in bisartans might be responsible for their poor cell membrane permeability. 

Study significance

The study identifies a new class of angiotensin II receptor blockers referred to as bisartans that contain two tetrazoles. Using two symmetrically arranged tetrazoles, bisartans are able to inhibit both type 1 angiotensin receptor and ACE2 enzyme via the interaction with their guanidino group and zinc atom, respectively.

Although bisartans fail to show high effectiveness in preventing viral infection, these drugs could play a potential role in preventing angiotensin II-induced pulmonary edema and angiotensin receptor-induced cytokine storm in severe COVID-19 patients.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Scrapping many Covid testing measures is a grave mistake, says London Medical Laboratory

Wastewater-based Epidemiology technique can help move toward a healthier and more sustainable world

by Medical Finance
May 28, 2022
0

Of the many contemporary conveniences often taken for granted in developed countries, modern sanitation may be among the most important....

Study: Human primary Omicron BA.1 and BA.2 infections result in sub-lineage-specific neutralization. Image Credit: Fit Ztudio/Shutterstock

Vaccine breakthrough infections with omicron sub-lineages induce cross-neutralizing antibodies

by Medical Finance
May 28, 2022
0

Scientists from the Medical University of Vienna, Austria, have recently evaluated the cross-neutralizing potency of serum samples collected from coronavirus...

Study: Whole-body metabolic modelling predicts isoleucine dependency of SARS-CoV-2 replication. Image Credit: CROCOTHERY/Shutterstock

Study investigates co-metabolism during SARS-CoV-2 infection

by Medical Finance
May 28, 2022
0

In a recent study posted to the bioRxiv* preprint server, researchers investigated host-virus co-metabolism during a severe acute respiratory syndrome...

Study: Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains. Image Credit: insta_photos/Shutterstock

Multivalent messenger ribonucleic acid-lipid nanoparticle vaccines against SARS-CoV-2

by Medical Finance
May 28, 2022
0

A recent article posted to the bioRxiv* preprint server analyzed multivalent messenger ribonucleic acid (mRNA)-lipid nanoparticle (LNP) vaccine constructs against certain...

Study: Loss of Y in leukocytes as a risk factor for critical COVID-19 in men. Image Credit: vchal/Shutterstock

Exploring loss of Y chromosome in white blood cells as a risk-factor of life-threatening COVID-19 in men

by Medical Finance
May 28, 2022
0

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), affects people by different severities. However,...

Study: Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm. Image Credit: ktsdesign / Shutterstock.com

Combating COVID cytokine storm with targeted nucleic acid therapies

by Medical Finance
May 28, 2022
0

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)  is a coronavirus with a single-stranded RNA (ssRNA) genome that belongs to...

Next Post
New predictive computer program could help detect individuals at high risk of depression

Magic mushroom compound helps to 'open up' depressed people's brains after use

E Coli

How could AI be used to predict infection outcomes?

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Social Distancing
    how robots will keep you in line
  • Study: Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance. Image Credit: Tong_stocker/Shutterstock
    Study predicts incidence rates of adverse outcomes of COVID-19 vaccination
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply